Mico BioMed Reports Operating Loss of 19.3 Billion KRW Last Year... Continued Deficit
Mico Biomed announced that its operating loss last year was 19.3 billion KRW, continuing its deficit. The net loss for the period was 25.7 billion KRW.
Hot Picks Today
Wealth Surpasses 20 Quadrillion Won... The Super-Rich Score Big, But Where Did the Money Flow?
- Trusted the 'Helper' and Opened the Door... She Returned and Stole Nearly 60 Million Won
- "Even as Stocks Tumble, I Trusted You"... The Secret of the ETF with Steady Upward Momentum [Weekend Money] [Weekend Money]
- "Kkokkalcorn Placed Next to Pork Belly Causes a Sensation... Sells Out Three Months’ Stock at Five Times the Usual Speed"
- "Just Drinking to Lift Your Mood"...Unexpected Warning: Raises Risk of Cancer Death
The company explained that sales in the molecular diagnostics sector (PCR devices and reagents, etc.) and the immunodiagnostics sector (RDT kits, etc.) decreased due to the transition to the COVID-19 endemic phase.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
